| SEATTLE, Jan. 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)
(Nasdaq and MTA: CTIC) announced today that it has received notification that
the NASDAQ Listing Qualifications Panel has granted CTI's request to transfer
the listing of its common stock from The NASDAQ Global Market to The NASDAQ
Capital Market, which will be effective with the open of trading on Thursday,
January 8, 2009. CTI's shares will continue to trade under the ticker symbol
CTIC.
CTI's continued li... |
